PATENT CLAIM ANALYSIS

Application Number: 15780599
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "085200"]

Abstract:
The present invention relates to cytokine fusion proteins and to nucleic acid molecules encoding such cytokine fusion proteins. The present invention further relates to cells, non-human organisms, pharmaceutical compositions and kits comprising the cytokine fusion proteins or the nucleic acid molecules encoding them, as well as to their use as medicaments.

Claim (Index 31):
A cytokine fusion protein according to any one of  claims 1  to  18 , a nucleic acid molecule according to any one of  claims 19  to  22 , a cell according to any one of  claims 23  to  25 , or a pharmaceutical composition according to  claim 27  or  28  for use in the treatment of a disease selected from the group consisting of cancer, infectious diseases, inflammatory diseases, metabolic diseases, autoimmune disorders, degenerative diseases, apoptosis-associated diseases and transplant rejections.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 93.0
- Lexical Diversity: 1.75
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15543566', '13946313', '13946438', '12151980', '15362632']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7521234999161757
- 35 USC 102 Novelty (BERT): 0.5674043366731589
- Combined Prediction Score: 0.733651583591874
- Mean Citation Score: 337.874784
- Max Citation Score: 485.10825
- Similarity Product: 323.8235006125421

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test